Newbridge Financial Services Group, Inc. Collegium Pharmaceutical, Inc Transaction History

Newbridge Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$17.5 - $21.35 $76,650 - $93,513	-4,380 Reduced 98.56%	64 $1,000
Q3 2021 Oct 27, 2021	BUY	$17.75 - $25.39 $77,745 - $111,208	4,380 Added 6843.75%	4,444 $88,000
Q1 2021 Sep 07, 2021	BUY	$19.25 - $26.1 $1,232 - $1,670	64 New	64 $2,000
Q4 2020 Sep 07, 2021	SELL	$17.83 - $22.29 $0 - $0	0 Closed	0 $0
Q3 2020 Sep 07, 2021	BUY	$15.78 - $20.82 $0 - $0	0 New	0 $0

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.